Estrogen and cognitive functioning in women

Endocrine Reviews

Volumn 24, Issue 2, 2003, Pages 133-151

  Sherwin, Barbara B ^a   McGill, James ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CHOLINE ACETYLTRANSFERASE; CONJUGATED ESTROGEN; CORTICOTROPIN; CYCLIC AMP; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; ESTROGEN RECEPTOR; EXCITOTOXIN; FREE RADICAL; GESTAGEN; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROCORTISONE; LEUPRORELIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTRANSMITTER; NEUROTROPHIN; PIPERAZINE ESTRONE SULFATE; PROGESTERONE; PSYCHOTROPIC AGENT; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SEX HORMONE; STEROID 21 MONOOXYGENASE; TESTOSTERONE; UNINDEXED DRUG;

AGING; ALZHEIMER DISEASE; BRAIN BLOOD FLOW; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; COGNITION; CONGENITAL ADRENAL HYPERPLASIA; DRUG MECHANISM; ESTROGEN THERAPY; FEMALE; HEADACHE; HUMAN; INSOMNIA; INTELLIGENCE QUOTIENT; MEMORY; MEMORY DISORDER; MENSTRUAL CYCLE; NEUROPROTECTION; NONHUMAN; OSTEOPOROSIS; OXIDATIVE STRESS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK; SEX DIFFERENCE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGING; ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; COGNITION; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; POSTMENOPAUSE; SEX CHARACTERISTICS;

EID: 0037397635     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2001-0016     Document Type: Review

References (175)

1. Singh GK, Kochanek KD, MacDorman MF 1996 Advance report of final mortality statistics, 1994. Mon Vital Stat Rep 45(Suppl):1-80
2. Amundsen DW, Diers CJ 1970 The age of menopause in classical Greece and Rome. Hum Biol 42:79-86
3. Amundsen DW, Diers CJ 1973 The age of menopause in medieval Europe. Hum Biol 45:605-612
4. McEwen BS, Alves SE 1999 Estrogen actions in the central nervous system. Endocr Rev 20:279-307
5. McEwen BS 2002 Estrogen action throughout the brain. Recent Prog Horm Res 57:357-384
6. Pfaff DW 1980 Estrogen and brain function. New York: Springer-Verlag
7. Stumpf WE, Sar M 1976 Steroid hormone target sites in the brain: the differential distribution J Steroid Biochem 7:1163-1170
8. Shughrue PJ, Merchenthaler I 2001 Distribution of estrogen receptors α immunoreactivity in the rat central nervous system. J Comp Neurol 43:64-81
9. Shughrue PJ, Scrimo PJ, Merchenthaler I 2000 Estrogen binding and estrogen receptor characterization (ER and ER) in the cholinergic neurons of the rat basal forebrain. Neuroscience 96:41-49
10. Lee SJ, McEwen BS 2001 Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications. Annu Rev Pharmacol Toxicol 41:569-591
11. Kelly MJ, Levin ER 2001 Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 12:152-156
12. Gould E, Woolley CS, Frankfurt M, McEwen BS 1990 Gonadal steroids regulate dendritic spine density in hippocampal pyramidal cells in adulthood. J Neurosci 10:1286-1291
13. Woolley CS, Gould E, Frankfurt M, McEwen BS 1990 Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J Neurosci 10:4035-4039
14. Sandstrom NJ, Williams CL 2001 Memory retention is modulated by acute estradiol and progesterone replacement. Behav Neurosci 115:384-393
15. Luine VN, Khylchevskaya RI, McEwen BS 1975 Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res 86:293-306
16. Davies P, Maloney AJF 1976 Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403-1406
17. Toran-Allerand CD, Singh M, Sétáló G 1999 Novel mechanisms of estrogen action in the brain: new players in an old story. Front Neuroendocrinol 20:97-121
18. Pike C 1999 Estrogen modulates neuronal Bel-xl expression and β-amyloid-induced apoptosis: relevence to Alzheimer's disease. J Neurochem 72:1552-1563
19. Green PS, Gridley KE, Simpkins JW 1998 Nuclear estrogen independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 84:7-10
20. Jaffe AB, Toron-Allerand CD, Greengard P, Gandy SE 1994 Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J Biol Chem 269:13065-13068
21. Squire LR 1992 Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 99:195-231
22. Baddeley A 1990 Human memory: theory and practice. Boston: Allyn & Bacon
23. Baddeley AD, Warrington EK 1970 Amnesia and the distinction between long- and short-term memory. J Verb Learn Verb Behav 9:176-189
24. Milner B 1972 Disorders of learning and memory after temporal lobe lesions in man. Clin Neurosurg 19:421-446
25. Tulving E 1972 Episodic and semantic memory. In: Tulving E, Donaldson W, eds. Organization of memory. New York: Academic Press; 381-403
26. Baddeley A, Logie R, Bressi S, Della Sala S, Spinnler H 1986 Dementia and working memory. Q J Exp Psychol A 38:603-618
27. Smith EE, Jonides J, Marshuetz C, Koeppe RA 1998 Components of verbal working memory: evidence from neuroimaging. Proc Natl Acad Sci USA 95:876-882
28. Goldman-Rakic PS 1992 Working memory and the mind. Sci Am 267:111-117
29. Cohen JD, Perlstein WM, Braver TS, Nystrom LE, Noll DC, Jonides J, Smith EE 1997 Temporal dynamics of brain activation during a working memory task. Nature 386:604-608
30. Petrides M, Alivisatos B, Meyer E 1993 Functional activation of the human frontal cortex during the performance of verbal working memory tasks. Proc Natl Acad Aci USA 90:878-882
31. Grady CL, Craik FIM 2000 Changes in memory processing with age. Curr Opin Neurobiol 10:224-231
32. Just MA, Carpenter PA, Keller TA 1996 The capacity theory of comprehension: new frontiers of evidence and arguments. Psychol Rev 103:773-780
33. Squire LR, Zola-Morgan S, Cave CB, Hainst F, Musen G, Suzuki WA 1993 Memory: organization of brain systems and cognition. In: Meyer DE, Kornblum S, eds. Attention and performance. Cambridge, MA: MIT Press; 393-423
34. Petersen RC, Jack CR, Xu Y-C, Waring SC, O'Brien PC, Smith GE, Ivnik RJ, Tangalos EG, Boeve BF, Kokmen E 2000 Memory and MRI-based hippocampal volumes in aging and AD. Neurology 54:581-587
35. Chowen JA, Torres-Alemán I, García-Segura LM 1992 Trophic effects of estradiol on fetal rat hypothalamic neurons. Neuroendocrinology 56:895-901
36. Luine VN 1985 Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89:484-490
37. Gibbs RB, Wu D, Hersh LB, Pfaff DW 1994 Effects of estrogen replacement on the relative levels of choline acetyltransferase, trkA, and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats. Exp Neurol 129:70-80
38. Shughrue PJ, Merchenthaler I 2000 Estrogen is more than just in "sex hormones"; novel sites for estrogen action in the hippocampus and cerebral cortex. Front Neuroendocinol 21:95-101
39. Halpern DF 1992 Sex differences in cognitive abilities. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates
40. White PC, Speiser PW 2000 Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245-291
41. Baker SW, Ehrhardt AA 1974 Prenatal androgen, intelligence, and cognitive sex differences. In: Friedman RC, Richart RM, Vande Wiele RL, eds. Sex differences in behavior. New York: Wiley; 53-76
42. Perlman S 1973 Cognitive abilities of children with hormone abnormalities: screening by psychoeducational tests. J Learn Disabil 6:26-36
43. Resnick SM, Berenbaum SA, Gottesman II, Bouchard TJ 1986 Early hormonal influences on cognitive functioning in congenital adrenal hyperplasia. Dev Psychol 22:191-198
44. Nordenstrom A, Servin A, Bohlin G, Larsson A, Wedell A 2002 Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperphasia. J Clin Endocrinol Metab 87:5119-5124
45. Singh RP, Carr DH 1966 The anatomy and histology of XO human embryos and fetuses. Anat Rec 155:369-383
46. Park E, Bailey JD, Cowell CA 1983 Growth and maturation of patients with Turner's syndrome. Pediatr Res 17:1-7
47. Hines M 1982 Prenatal gonadal hormones and sex differences in human behavior. Psychol Bull 92:56-80
48. Ross JL, Roeltgen D, Feuillan P, Kushner H, Cutler GB 2000 Use of estrogen in young girls with Turner syndrome: effects on memory. Neurology 54:164-170
49. Bidlingmaier F, Strom TM, Dorr HG, Eisenmenger W, Knorr D 1987 Estrone and estradiol concentrations in human ovaries, testes, and adrenals during the first two years of life. J Clin Endocrinol Metab 65:862-867
50. Goy RW, Phoenix CH 1972 The effects of testosterone propionate administered before birth on the development of behavior in genetic female rhesus monkeys. In: Sawyer CH, Gorski RA, eds. Steroid hormones and brain function. Berkeley, CA: University of California Press; 193-201
51. Dor-Shav NK 1976 In search of pre-menstrual tension: note on sex differences in psychological differentiations as a function of cyclical physiological changes. Percept Mot Skills 42:1139-1142
52. Pierson WR, Lockhart A 1963 Effect of menstruation on simple reaction and movement time. Br Med J 1:796-797
53. Wuttke W, Arnold P, Creutzfeldt O, Langenstein S, Tirsch W 1975 Circulating hormones, EEG, and performance in psychological tests of women with and without oral contraceptives. Psychoneuroendocrinology 1:141-151
54. Zimmerman E, Parlee MB 1973 Behavioral changes associated with the menstrual cycle: an experimental investigation. J Appl Soc Psychol 3:335-344
55. Broverman DM, Vogel W, Klaiber EL, Majcher D, Shea D, Paul V 1981 Changes in cognitive task performance across the menstrual cycle. J Comp Physiol Psychol 95:646-654
56. Hampson E 1990 Estrogen-related variations in human spatial and articulator-motor skills. Psychoneuroendocrinology 15:97-111
57. Gordon HW, Lee PA 1993 No difference in cognitive performance between phases of the menstrual cycle. Psychoneuroendocrinology 18:521-531
58. Keenan PA, Lindamer LA, Jong SK 1995 Menstrual phase-independent retrieval deficit in women with PMS. Biol Psychiatry 38:369-377
59. Morgan M, Rapkin AJ, D'Elia L, Reading A, Goldman L 1996 Cognitive functioning in premenstrual syndrome. Obstet Gynecol 88:961-966
60. Hampson E 1990 Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cogn 14:26-43
61. Hampson E, Kimura D 1988 Reciprocal effects of hormonal fluctuations on human motor and perceptual-spatial skills. Behav Neurosci 102:456-459
62. Maki PM, Pich JB, Rosenbaum S 2002 Implicit memory varies across the menstrual cycle: estrogen effects in young women. Neuropsychologia 40:518-529
63. Phillips SM, Sherwin BB 1992 Variations in memory function and sex steroid hormones across the menstrual cycle. Psychoneuroendocrinology 17:497-506
64. Sanders G, Sjodin M, de Chastelaine M 2002 On the elusive nature of sex differences in cognition: hormonal influences contributing to within-sex variation. Arch Sex Behav 31:145-152
65. Deleted in proof
66. Deleted in proof
67. Frye CA 1995 Estrus-associated decrements in a water maze task are limited to acquisition. Physiol Behav 57:5-14
68. Fugger HN, Cunningham SG, Rissman EF, Foster TC 1998 Sex differences in the activational effect of ER on spatial learning. Horm Behav 34:163-170
69. Lacreuse A, Herndon JG, Moss MB 2000 Cognitive function in aged ovariectomized female rhesus monkeys. Behav Neurosci 114:506-513
70. Caldwell BM, Watson RI 1952 An evaluation of psychologic effects of sex hormone administration in aged women. I. Results of therapy after six months. J Gerontol 7:228-244
71. Campbell S, Whitehead M 1977 Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 4:31-47
72. Miller KJ, Conney JC, Rasgon NL, Fairbanks LA, Small GW 2002 Mood symptoms and cognitive performance in women estrogen users and nonusers and men. J Am Geriatr Soc 50:1826-1830
73. Hackman BW, Galbraith D 1977 Six-month study of oestrogen therapy with piperazine oestrone sulphate and its effects on memory. Curr Med Res Opin 4:21-27
74. Fedor-Freybergh P 1977 The influence of oestrogens on the well-being and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand Suppl 64:1-92
75. Rauramo L, Lagerspetz K, Engblom P, Punnonen R 1975 The effect of castration and peroral estrogen therapy on some psychological functions. Horm Res 3:94-104
76. Vanhulle G, Demol R 1976 A double-blind study into the influence of estriol on a number of psychological tests in post-menopausal women. In: van Keep PA, Greenblatt RB, Albeaux-Fernet M, eds. Consensus on menopause research: a summary of international opinion. Baltimore, MD: University Park Press; 94-99
77. Sherwin BB 1988 Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13:345-357
78. Sherwin BB, Phillips S 1990 Estrogen and cognitive functioning in surgically menopausal women. Ann NY Acad Sci 592:474-475
79. Phillips SM, Sherwin BB 1992 Effects on estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17:485-495
80. Duka T, Tasker R, McGowan JF 2000 The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology 149:129-139
81. Wolf OT, Kudielka BM, Hellhammer DH, Torber S, McEwen BS, Kirschbaum C 1999 Two weeks of transdermal estradiol treatment in postmenopausal elderly women and its effect on memory and mood: verbal memory changes are associated with the treatment induced estradiol levels. Psychoneuroendocrinology 24:727-741
82. Ditkoff EC, Crary WG, Cristo M, Lobo RA 1991 Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 78:991-995
83. Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala K, Erkkola R, Portin R 1998 The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol 91:459-466
84. Janowsky JS, Chavez B, Orwoll E 2000 Sex steroids modify working memory. J Cogn Neurosci 12:407-414
85. Binder EF, Schechtman KB, Birge SJ, Williams DB, Koher WM 2001 Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 38:137-146
86. Sherwin BB, Tulandi T 1996 "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 81:2545-2549
87. Zec RF, Trivendi MA 2002 The effects of estrogen replacement therapy on neuropsychological function in postmenopausal women with and without dementia: a critical and theoretical review. Neuropsychol Rev 12:65-109
88. Barrett-Connor E, Kritz-Silverstein D 1993 Estrogen replacement therapy and cognitive function in older women. JAMA 269:2637-2641
89. Robinson D, Friedman L, Marcus R, Tinklenberg J, Yesavage J 1994 Estrogen replacement therapy and memory in older women. J Am Geriatr Soc 42:919-922
90. Kampen DL, Sherwin BB 1994 Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 83:979-983
91. Kimura D 1995 Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm Behav 29:312-321
92. Hogervorst E, Boshuisen M, Riedel W, Willeken C, Jolles J 1999 The effect of hormone replacement therapy on cognitive function in elderly women. Psychoneuroendocrinology 24:43-68
93. Carlson LE, Sherwin BB 1998 Steroid hormones, memory and mood in a healthy elderly population. Psychoneuroendocrinology 23:583-603
94. Carlson LE, Sherwin BB 2000 Higher levels of plasma estradiol and testosterone in healthy elderly men compared with age-matched women may protect aspects of explicit memory. Menopause 7:168-177
95. Duff SJ, Hampson E 2000 A beneficial effect of estrogen on working memory in postmenopausal women taking hormone replacement therapy. Horm Behav 38:262-276
96. Drake EB, Henderson VW, Stanczyk FZ, McCleary CA, Brown WS, Smith CA, Rizzo AA, Murdock GA, Buckwalter JG 2000 Associations between circulating sex steroid hormones and cognition in normal elderly women. Neurology 54:599-603
97. Maki PM, Zonderman AB, Resnick SM 2001 Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am J Psychiatry 158:227-233
98. Verghese J, Kuslansky G, Katz MJ, Sliwinski M, Crystal HA, Buschke H, Lipton RB 2000 Cognitive performance in surgically menopausal women on estrogen. Neurology 55:872-874
99. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG 1990 Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 163:1438-1444
100. Matthews K, Cauley J, Yaffe K, Zmuda JM 1999 Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 47:518-523
101. Resnick SM, Metter EJ, Zonderman AB 1997 Estrogen replacement therapy and longitudinal decline in visual memory: a possible protective effect? Neurology 49:1491-1497
102. Jacobs DM, Tang M-X, Stern Y, Sano M, Marder K, Bell KL, Schofield P, Dooneief G, Gurland B, Mayeux R 1998 Cognitive function in nondemented older women who took estrogen after menopause. Neurology 50:368-373
103. Steffens DC, Norton MC, Plassman BL, Tschanz JT, Wyse BW, Welsh-Bohmer KA, Anthony JC, Breitner JC 1999 Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. J Am Geriatr Soc 47:1171-1175
104. Yaffe K, Lui L-Y, Grady D, Cauley J, Kramer J, Cummings SR 2000 Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet 356:708-712
105. Grodstein F, Chen J, Pollen DA, Albert MS, Wilson RS, Folstein MF, Evans DA, Stampfer MJ 2000 Postmenopausal hormone therapy and cognitive function in healthy older women. J Am Geriatr Soc 48:746-752
106. Rice MM, Graves AB, McCurry SM, Gibbons LE, Bowen JD, McCormick WC, Larson EB 2000 Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: the Kame project. Arch Intern Med 160:1641-1649
107. Yaffe K, Haan M, Byers A, Tangen C, Kuller L 2000 Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology 54:1949-1954
108. Fillenbaum GG, Hanlon JT, Landerman LR, Schmader KE 2001 Impact of estrogen use on decline in cognitive function in a representative sample of older community-resident women. Am J Epidemiol 153:137-144
109. deMoraes SA, Szklo M, Park E 2001 Projective assessment of estrogen replacement therapy and cognitive functioning. Am J Epidemiol 154:733-739
110. Deleted in proof
111. Barrett-Connor E 1991 Postmenopausal estrogen and prevention bias. Ann Intern Med 115:455-456
112. Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P 1996 Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol 143:971-978
113. Derby CA, Hume AL, McPhillips JB, Barbour MM, Carleton RA 1995 Prior and current health characteristics of postmenopausal estrogen replacement therapy users compared with nonusers. Am J Obstet Gvnecol 173:544-550
114. Dietrich T, Krings T, Neulen J, Willmes K, Erberich S, Thron A, Sturm W 2001 Effects of blood estrogen level on cortical activation patterns during cognitive activation as measured by functional MRI. Neuroimage 13:425-432
115. Shaywitz SE, Shaywitz BA, Pugh KR, Fulbright RK, Skudlarski P, Mencl WE, Constable RT, Naftolin F, Palter SF, Marchione KE, Katz L, Shankweiler DP, Fletcher JM, Lacadie C, Keltz M, Gore JC 1999 Effect of estrogen on brain activation patterns in post-menopausal women during working memory tasks. JAMA 281:1197-1202
116. Reiman EM, Armstrong SM, Matt KS, Mattox JH 1996 The application of position emission tomography to the study of the normal menstrual cycle. Hum Reprod 11:2799-2805
117. Maki PM, Resnick SM 2000 Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 21:373-383
118. Berman KF, Schmidt PJ, Rubinow DR, Danaceau MA, Van Horn JD, Esposito G, Ostrem JL, Weinberger DR 1997 Modulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in women. Proc Natl Acad Sci USA 94:8836-8841
119. Greene RA 2000 Estrogen and cerebral blood flow: a mechanism to explain the impact of estrogen on the incidence and treatment of Alzheimer's disease. Int J Fertil Menopausal Stud 45:253-257
120. Luoto R, Manolio T, Meilahn E, Bhadelia R, Furberg C, Cooper L, Kraut M 2000 Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health Study. J Am Geriatr Soc 48:467-472
121. Henderson VW 1997 Estrogen replacement therapy for the prevention and treatment of Alzheimer's disease. CNS Drugs 8:343-351
122. Gao S, Hendrie HC, Hall KS, Hui S 1998 The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry 55:809-815
123. Yaffe K, Sawaya G, Lieberburg I, Grady D 1998 Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279:688-695
124. Heyman A, Wilkinson WE, Stafford JA 1984 Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 15:335-341
125. Amaducci LA, Fratiglioni L, Rocca WA 1986 Risk factors for clinically diagnosed Alzheimer's disease: a case control study of an Italian population. Neurology 36:922-931
126. Broe GA, Henderson AS, Creasey H, McCusker E, Korten AE, Jorm AF, Longley W, Anthony JC 1990 A case-control study of Alzheimer's disease in Australia. Neurology 40:1698-1707
127. Graves AB, White E, Koepsell TD, Reifler BV, van Belle G, Larson EB, Raskind M 1990 A case-control study of Alzheimer's disease. Arm Neurol 28:766-774
128. Brenner DE, Kukull WA, Stergachis A, van Belle G, Bowen JD, McCormick WC, Teri L, Larson EB 1994 Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol 140:262-267
129. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG 1994 Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects. Arch Neurol 51:896-900
130. Mortel KF, Meyer JS 1995 Lack of postmenopausal estrogen replacement therapy and the risk of dementia. J Neuropsychiatry Clin Neurosci 7:334-337
131. Paganini-Hill A, Henderson VW 1996 Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 156:2213-2217
132. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R 1996 Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432
133. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Lingle DD, Metter E 1997 A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48:1517-1521
134. Baldereschi M, Di Carlo A, Lepore V, Bracco L, Maggi S, Grigoletto F, Scarlato G, Amaducci L, ILSA Working Group 1998 Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology 50:996-1002
135. Slooter AJC, Bronzova J, Witteman CM, Van Broeckhoven C, Hofman A, van Duijn CM 1999 Estrogen use and early onset Alzheimer's disease: a population-based study. J Neurol Neurosurg Psychiatry 67:779-781
136. Waring SC, Rocca WA, Petersen RC, O'Brien PC, Tangalos EG, Kokmen E 1999 Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology 52:965-970
137. Zandi PP, Carlson MC, Plassman BL, Welsh-Bohmer KA, Mayer LS, Steffens DC, Breitner JCS 2002 Hormone replacement therapy and incidence of Alzheimer's disease in older women. JAMA 288:2123-2129
138. Carlson LE, Sherwin BB, Chertkow HM 1999 Relationships between dehydroepiandrosterone sulfate (DHEAS) and cortisol (CRT) plasma levels and everyday memory in Alzheimer's disease patients compared to healthy controls. Horm Behav 35:254-263
139. LeBlanc ES, Janowsky J, Chan BK, Nelson HD 2001 Hormone replacement therapy and cognition: systematic review and metaanalysis. JAMA 285:1489-1499
140. Honjo H, Ogino Y, Naitoh K, Urabe M, Kitawaki J, Yasuda J, Yamamoto T, Ishihara S, Okada H, Yonezawa T, Hayashi K, Nambara T 1989 In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer's type). J Steroid Biochem 34:521-525
141. Fillit H, Weinreb H, Cholst I, Luine V, McEwen B, Amador R, Zabriskie J 1986 Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology 11:337-345
142. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N 1994 Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J 41:361-371
143. Honjo H, Ogino Y, Tanaka K, Urabe M, Kashiwagi T, Ishihara S, Okada H, Araki K, Fushiki S, Nakajima K, Hayashi M, Sakaki T 1993 An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer's type: a placebo-controlled, double-blind study. J Jpn Men Soc 1:167-171
144. Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, Veith RC, Plymate SR 1999 Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology 24:657-677
145. Wang PN, Liao SQ, Liu RS, Liu CY, Chao HT, Lu SR, Yu HY, Wang SJ, Liu HC 2000 Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology 54:2061-2066
146. Mulnard RA, Cotman CW, Kawas CW, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ 2000 Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. JAMA 283:1007-1015
147. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR 2000 Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54:295-301
148. Schneider LS, Farlow MR, Henderson VW, Pogoda JM 1996 Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 46:1580-1584
149. Draper MW, Flowers DE, Huster WJ, Neild JA, Harper KD, Arnaud C 1996 A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women. J Bone Miner Res 11:835-842
150. Walsh BW, Kuller LH, Wild RA, Paul S, Farmer M, Lawrence JB, Shah AS, Anderson PW 1998 Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA 279:1445-1451
151. Nickelsen T, Lufkin EG, Riggs BL, Cox DA, Crook TH 1999 Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects of cognitive function and mood in postmenopausal women. Psychoneuroendocrinology 24:115-128
152. Yaffe K, Kruger K, Sarkar S, Grady D, Barrett-Connor E, Cox DA, Nickersen T 2001 Cognitive function in postmenopausal women treated with ralozifene. N Engl J Med 3441:1207-1213
153. Lacreuse A, Wilson ME, Herndon JG 2002 Estradiol, but not raloxirene, improves aspects of spatial working memory in aged ovariectomized rhesus monkeys. Neurobiol Aging 23:589-600
154. Sherwin BB, Gelfand MM 1985 Sex steroids and affect in the surgical menopause: a double-blind, cross-over study. Psychoneuroendocrinology 10:325-335
155. Sherwin BB 1988 Affective changes with estrogen and androgen replacement therapy in surgically menopausal women. J Affect Disord 14:177-187
156. Sherwin BB 1991 The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 72:336-343
157. Schneider MA, Brotherton PL, Hailes J 1977 The effect of exogenous oestrogens on depression in menopausal women. Med J Aust 2:162-163
158. Sherwin BB 1991 Estrogen and refractory depression. In: Amsterdam JD, ed. Refractory depression (Advances in neuropsychiatry and psychopharmacology, vol. 2). New York: Raven Press; 209-218
159. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y 1979 Estrogen therapy for severe persistent depressions in women. Arch Gen Psychiatry 36:550-554
160. Schmidt PJ, Nieman L, Danaceau MA, Tobin MB, Roca CA, Murphy JH, Rubinow DR 2000 Estrogen replacement in perimenopause-related depression: a preliminary report. Am J Obstet Gynecol 183:414-420
161. 3H-imipramine binding sites in surgically menopausal women. Biol Psychiatry 28:339-348
162. Holst J, Bäckström T, Hammarbäck S, von Schoultz B 1989 Progestogen addition during oestrogen replacement therapy - effects on vasomotor symptoms and mood. Maturitas 11:13-20
163. Magos AL, Brewster E, Singh R, O'Dowd T, Brincat M, Studd JW 1986 The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. Br J Obstet Gynaecol 93:1290-1296
164. Zweifel JE, O'Brien WH 1997 A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 22:189-212
165. Smith VR, Minoshima S, Kuhl DE, Zubieta JK 2001 Effects of long term-hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J Clin Endocrinol Metab 86:679-684
166. Writing Group for the PEPI Trial 1995 Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 273:199-208
167. Steingold KA, Cefalu W, Pardridge W, Judd HL, Chaudhuri G 1986 Enhanced hepatic extraction of estrogens used for replacement therapy. J Clin Endocrinol Metab 62:761-766
168. Englund DE, Johansson ED 1977 Pharmacokinetic and pharmacodynamic studies on oestradiol valerianate administered orally to postmenopausal women. Acta Obstet Gynecol Scand Suppl 65:27-31
169. Ansbacher R 2001 The pharmacokinetics and efficacy of different estrogens are not equivalent. Am J Obstet Gynecol 184:255-263
170. Brinton RD, Proffitt P, Tran J, Luu R 1997 Equilin, a principal component of the estrogen replacement therapy Premarin, increases the growth of cortical neurons via an NMDA receptor-dependent mechanism. Exp Neurol 147:211-220
171. Washburn SA, Lewis CE, Johnson JE, Voytko ML, Shively CA 1997 17-Dihydroequilenin increases hippocampal dendritic spine density in ovariectomized rats. Brain Res 758:241-244
172. Cohen J 1992 A power primer. Psychol Bull 112:155-159
173. Marder K, Sano M 2000 Estrogen to treat Alzheimer's disease: too little, too late? Neurology 54:2035-2037
174. Shumaker SA, Reboussin BA, Espeland MA, Rapp SR, McBee WL, Dailey M, Bowen D, Terrell T, Jones BN 1998 The Women's Health Initiative Memory Study (WHIMS): a trial of the effect of estrogen therapy in preventing and slowing the progression of dementia. Control Clin Trials 19:604-621
175. Writing Group for the Women's Health Initiative Investigators 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288:321-333